Mark Kaye - Mar 3, 2025 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & CFO
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol: ELV
Transactions as of: Mar 3, 2025
Transactions value $: -$106,785
Form type: 4
Date filed: 3/5/2025, 04:44 PM
Previous filing: Feb 26, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	-$107K	-270	-1.33%	$395.50	20K	Mar 3, 2025	Direct	F1
transaction	ELV	Common Stock	Award	$0	+3.6K	+18.06%	$0.00	23.6K	Mar 3, 2025	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+13.7K		$0.00	13.7K	Mar 3, 2025	Common Stock	13.7K	$395.50	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows:1,201 shares each on 3/3/2026 and 3/3/2027, and 1,202 shares on 3/3/2028.
F3	Balance includes 17.59 shares acquired on December 20, 2024 through a dividend reinvestment plan.
F4	The option represents a right to purchase a total of 13,713 shares, and is exercisable in three annual installments of 4,571 shares each, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.